SM
LSTA icon

Sabby Management’s Lisata Therapeutics LSTA Stock Holding History

Sabby Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-178
Closed -$225K – 176
2021
Q4 		$225K Sell
178
-246
-58% -$3.8K 0.03% 133
2021
Q3 		$776K Sell
424
-270
-39% -$5.29K 0.1% 100
2021
Q2 		$1.68M Sell
694
-103
-13% -$2.44K 0.24% 65
2021
Q1 		$2.31M Buy
797
+790
+11,286% +$23.9K 0.45% 44
2020
Q4 		$16K Sell
7
-102
-94% -$2.42K ﹤0.01% 106
2020
Q3 		$293K Buy
+109
New +$3.45K 0.04% 94
2014
Q4 		– Sell
-2
Closed -$145 – 268
2014
Q3 		$145 Sell
2
-5
-71% -$4.38K 0.01% 225
2014
Q2 		$658K Buy
7
+2
+40% +$1.94K 0.03% 177
2014
Q1 		$538K Buy
+5
New +$5.42K 0.03% 175

Other funds holding LSTA

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CW
Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Sabby Management's LSTA Position: Q1 2023 in Review

Sabby Management sold out of Lisata Therapeutics (LSTA) in Q1 2023, closing a stake of 68,462 shares — an estimated $173K sold.

Sabby Management first reported a position in LSTA in Q2 2014 and held it in 11 quarters. The position peaked at $1.48M in Q1 2022. 21 funds tracked by Wall St. Rank hold LSTA as of Q1 2023.

  • Sabby Management reported no remaining Lisata Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Sabby Management sold 68,462 Lisata Therapeutics shares in Q1 2023, an estimated $173K.
  • Sabby Management first reported a position in Lisata Therapeutics in Q2 2014 and held it in 11 quarters.
  • Sabby Management's Lisata Therapeutics position peaked at $1.48M in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2023.

Based on Sabby Management's 13F filing for Q1 2023, filed 15 May 2023.